Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Vo

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Cancer Genetics|April 18, 2025
Analytical validation of the Belay Vantage™ assay for evaluation of MGMT promoter methylation using enzymatically converted tumorDNA from cerebrospinal fluidKala F Schilter, Qian Nie, Jennifer N Adams, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 8, 2021
Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patientsChristian Kjellman, Angela Q Maldonado, Kristoffer Sjöholm, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 15, 2021
Clazakizumab for desensitization in highly sensitized patients awaiting transplantationAshley A Vo, Edmund Huang, Noriko Ammerman, et al.
Transplantation|October 23, 2020
Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)Stanley C Jordan, Christophe Legendre, Niraj M Desai, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 6, 2024
Long-term outcomes at 5 years posttransplant in imlifidase-desensitized kidney transplant patientsStanley C Jordan, Angela Q Maldonado, Bonnie E Lonze, et al.
Cancers|April 14, 2026
Clinical Utility of Belay Summit™ Cerebrospinal Fluid Test to Inform Diagnosis and Management of Central Nervous System Cancer-A Single Institution Case SeriesMichael Youssef, Alexandra Larson, Vindhya Udhane, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|October 16, 2019
Normal Ranges of Left Ventricular Strain by Three-Dimensional Speckle-Tracking Echocardiography in Adults: A Systematic Review and Meta-AnalysisVien T Truong, Hoang T Phan, Khanh N P Pham, et al.
The Journal of Allergy and Clinical Immunology|January 3, 2017
Update on the use of immunoglobulin in human disease: A review of evidenceElena E Perez, Jordan S Orange, Francisco Bonilla, et al.
The Journal of Molecular Diagnostics : JMD|April 25, 2025
Analytical Validation and Clinical Sensitivity of the Belay Summit Assay for the Detection of DNA Variants in Cerebrospinal Fluid of Primary and Metastatic Central Nervous System CancerQian Nie, Kala F Schilter, Kyle M Hernandez, et al.
Cancers|January 28, 2026
Analytical Validation and Clinical Sensitivity of the Belay Summit™ 2.0 Cerebrospinal Fluid Liquid Biopsy Test-An Expanded Comprehensive Genomic Profiling Platform for Central Nervous System MalignanciesSakshi Khurana, Viriya Keo, Alexandra Larson, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Cancer Genetics|April 18, 2025
Analytical validation of the Belay Vantage™ assay for evaluation of MGMT promoter methylation using enzymatically converted tumorDNA from cerebrospinal fluidKala F Schilter, Qian Nie, Jennifer N Adams, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 8, 2021
Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patientsChristian Kjellman, Angela Q Maldonado, Kristoffer Sjöholm, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 15, 2021
Clazakizumab for desensitization in highly sensitized patients awaiting transplantationAshley A Vo, Edmund Huang, Noriko Ammerman, et al.
Transplantation|October 23, 2020
Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)Stanley C Jordan, Christophe Legendre, Niraj M Desai, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 6, 2024
Long-term outcomes at 5 years posttransplant in imlifidase-desensitized kidney transplant patientsStanley C Jordan, Angela Q Maldonado, Bonnie E Lonze, et al.
Cancers|April 14, 2026
Clinical Utility of Belay Summit™ Cerebrospinal Fluid Test to Inform Diagnosis and Management of Central Nervous System Cancer-A Single Institution Case SeriesMichael Youssef, Alexandra Larson, Vindhya Udhane, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|October 16, 2019
Normal Ranges of Left Ventricular Strain by Three-Dimensional Speckle-Tracking Echocardiography in Adults: A Systematic Review and Meta-AnalysisVien T Truong, Hoang T Phan, Khanh N P Pham, et al.
The Journal of Allergy and Clinical Immunology|January 3, 2017
Update on the use of immunoglobulin in human disease: A review of evidenceElena E Perez, Jordan S Orange, Francisco Bonilla, et al.
The Journal of Molecular Diagnostics : JMD|April 25, 2025
Analytical Validation and Clinical Sensitivity of the Belay Summit Assay for the Detection of DNA Variants in Cerebrospinal Fluid of Primary and Metastatic Central Nervous System CancerQian Nie, Kala F Schilter, Kyle M Hernandez, et al.
Cancers|January 28, 2026
Analytical Validation and Clinical Sensitivity of the Belay Summit™ 2.0 Cerebrospinal Fluid Liquid Biopsy Test-An Expanded Comprehensive Genomic Profiling Platform for Central Nervous System MalignanciesSakshi Khurana, Viriya Keo, Alexandra Larson, et al.
Pageof 15